Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenus
6,561
6,603
7,384
7,085
5,213
3,192
Croissance des revenus (H/H)
-4%
-11%
4%
36%
63%
14%
Coût des ventes
4,855
4,358
4,538
4,277
2,942
1,678
Bénéfice brut
1,706
2,244
2,845
2,808
2,270
1,514
Vente, Général et Administration
965
860
782
722
652
435
Recherche et développement
257
229
254
229
211
151
Frais d'exploitation
1,174
1,154
1,132
1,028
841
557
Autres revenus (charges) non opérationnels
-8
0
1
2
-12
-4
Bénéfice avant impôts
800
664
2,488
2,585
3,684
2,218
Charge d'impôt sur le revenu
163
216
338
313
292
189
Bénéfice net
612
405
2,024
2,006
2,874
1,749
Croissance du bénéfice net
-36%
-80%
1%
-30%
64%
108%
Actions en circulation (diluées)
868.8
863.04
865.32
864.89
870.95
799
Variation des actions (H-H)
0%
0%
0%
-1%
9%
7%
EPS (dilué)
0.7
0.46
2.34
2.32
3.3
2.19
Croissance du EPS
-36%
-80%
1%
-30%
51%
94%
Flux de trésorerie libre
1,005
740
836
908
1,055
842
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
26%
33.98%
38.52%
39.63%
43.54%
47.43%
Marge opérationnelle
8.09%
16.49%
23.18%
25.1%
27.41%
29.94%
Marge bénéficiaire
9.32%
6.13%
27.41%
28.31%
55.13%
54.79%
Marge du flux de trésorerie libre
15.31%
11.2%
11.32%
12.81%
20.23%
26.37%
EBITDA
--
1,241
1,838
1,889
1,500
1,013
Marge EBITDA
--
18.79%
24.89%
26.66%
28.77%
31.73%
D&A pour le résultat opérationnel
--
152
126
110
71
57
EBIT
531
1,089
1,712
1,779
1,429
956
Marge EBIT
8.09%
16.49%
23.18%
25.1%
27.41%
29.94%
Taux d'imposition effectif
20.37%
32.53%
13.58%
12.1%
7.92%
8.52%
Follow-Up Questions
Quels sont les états financiers clés de Hangzhou Tigermed Consulting Co Ltd ?
Quels sont les ratios financiers clés pour HTMDF ?
Comment les revenus de Hangzhou Tigermed Consulting Co Ltd sont-ils répartis par segment ou géographie ?
Hangzhou Tigermed Consulting Co Ltd est-elle rentable ?
Hangzhou Tigermed Consulting Co Ltd a-t-elle des passifs ?
Combien d'actions en circulation Hangzhou Tigermed Consulting Co Ltd a-t-elle ?
Statistiques clés
Clôture préc.
--
Prix d'ouverture
--
Plage de la journée
-
Plage de 52 semaines
-
Volume
--
Volume moyen
--
BPA (TTM)
--
Rendement en dividend
--
Capitalisation boursière
--
Qu’est-ce que HTMDF ?
Hangzhou Tigermed Consulting Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Hangzhou, Zhejiang and currently employs 10,185 full-time employees. The company went IPO on 2012-08-17. Hangzhou Tigermed Consulting Co Ltd is a China-based holding company engaged in providing clinical trial services for research and development of new drugs. The firm operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary. The firm conducts its businesses in the domestic and overseas markets.